Intestinal IFN-γ–producing type 1 regulatory T cells coexpress CCR5 and programmed cell death protein 1 and downregulate IL-10 in the inflamed guts of patients with inflammatory bowel disease

Moore, 2001, Interleukin-10 and the interleukin-10 receptor, Annu Rev Immunol, 19, 683, 10.1146/annurev.immunol.19.1.683 Sabat, 2010, Biology of interleukin-10, Cytokine Growth Factor Rev, 21, 331, 10.1016/j.cytogfr.2010.09.002 Glocker, 2011, IL-10 and IL-10 receptor defects in humans, Ann N Y Acad Sci, 1246, 102, 10.1111/j.1749-6632.2011.06339.x Kuhn, 1993, Interleukin-10-deficient mice develop chronic enterocolitis, Cell, 75, 263, 10.1016/0092-8674(93)80068-P Sellon, 1998, Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice, Infect Immun, 66, 5224, 10.1128/IAI.66.11.5224-5231.1998 Roers, 2004, T cell-specific inactivation of the interleukin 10 gene in mice results in enhanced T cell responses but normal innate responses to lipopolysaccharide or skin irritation, J Exp Med, 200, 1289, 10.1084/jem.20041789 Rubtsov, 2008, Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces, Immunity, 28, 546, 10.1016/j.immuni.2008.02.017 Asseman, 1999, An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation, J Exp Med, 190, 995, 10.1084/jem.190.7.995 Uhlig, 2006, Characterization of Foxp3+CD4+CD25+ and IL-10-secreting CD4+CD25+ T cells during cure of colitis, J Immunol, 177, 5852, 10.4049/jimmunol.177.9.5852 Huber, 2011, Th17 cells express interleukin-10 receptor and are controlled by Foxp3 and Foxp3+ regulatory CD4+ T cells in an interleukin-10-dependent manner, Immunity, 34, 554, 10.1016/j.immuni.2011.01.020 Zigmond, 2014, Macrophage-restricted interleukin-10 receptor deficiency, but not IL-10 deficiency, causes severe spontaneous colitis, Immunity, 40, 720, 10.1016/j.immuni.2014.03.012 Groux, 1997, A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis, Nature, 389, 737, 10.1038/39614 Maynard, 2007, Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10, Nat Immunol, 8, 931, 10.1038/ni1504 Vieira, 2004, IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells, J Immunol, 172, 5986, 10.4049/jimmunol.172.10.5986 O'Garra, 2004, IL-10-producing and naturally occurring CD4+ Tregs: limiting collateral damage, J Clin Invest, 114, 1372, 10.1172/JCI23215 Akdis, 2004, Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells, J Exp Med, 199, 1567, 10.1084/jem.20032058 Chaudhry, 2011, Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation, Immunity, 34, 566, 10.1016/j.immuni.2011.03.018 Barrat, 2002, In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines, J Exp Med, 195, 603, 10.1084/jem.20011629 Kemper, 2003, Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype, Nature, 421, 388, 10.1038/nature01315 Levings, 2005, Differentiation of TR1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells, Blood, 105, 1162, 10.1182/blood-2004-03-1211 Allan, 2008, CD4+ T-regulatory cells: toward therapy for human diseases, Immunol Rev, 223, 391, 10.1111/j.1600-065X.2008.00634.x Desreumaux, 2012, Safety and efficacy of antigen-specific regulatory T-cell therapy for patients with refractory Crohn's disease, Gastroenterology, 143, 1207, 10.1053/j.gastro.2012.07.116 Bacchetta, 2014, Immunological outcome in haploidentical-HSC transplanted patients treated with IL-10-anergized donor T cells, Front Immunol, 5, 16, 10.3389/fimmu.2014.00016 Haringer, 2009, Identification and characterization of IL-10/IFN-gamma-producing effector-like T cells with regulatory function in human blood, J Exp Med, 206, 1009, 10.1084/jem.20082238 Facciotti, 2016, IL-10-producing forkhead box protein 3-negative regulatory T cells inhibit B-cell responses and are involved in systemic lupus erythematosus, J Allergy Clin Immunol, 137, 318, 10.1016/j.jaci.2015.06.044 Gagliani, 2013, Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells, Nat Med, 19, 739, 10.1038/nm.3179 Caprioli, 2008, Autocrine regulation of IL-21 production in human T lymphocytes, J Immunol, 180, 1800, 10.4049/jimmunol.180.3.1800 Kastirr, 2014, IL-21 is a central memory T cell-associated cytokine that inhibits the generation of pathogenic Th1/17 effector cells, J Immunol, 193, 3322, 10.4049/jimmunol.1400775 Okamura, 2009, CD4+CD25-LAG3+ regulatory T cells controlled by the transcription factor Egr-2, Proc Natl Acad Sci U S A, 106, 13974, 10.1073/pnas.0906872106 Kamanaka, 2006, Expression of interleukin-10 in intestinal lymphocytes detected by an interleukin-10 reporter knockin tiger mouse, Immunity, 25, 941, 10.1016/j.immuni.2006.09.013 Acosta-Rodriguez, 2007, Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells, Nat Immunol, 8, 639, 10.1038/ni1467 Annunziato, 2007, Phenotypic and functional features of human Th17 cells, J Exp Med, 204, 1849, 10.1084/jem.20070663 Izcue, 2008, Interleukin-23 restrains regulatory T cell activity to drive T cell-dependent colitis, Immunity, 28, 559, 10.1016/j.immuni.2008.02.019 Yen, 2006, IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6, J Clin Invest, 116, 1310, 10.1172/JCI21404 Kullberg, 2006, IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis, J Exp Med, 203, 2485, 10.1084/jem.20061082 Duerr, 2006, A genome-wide association study identifies IL23R as an inflammatory bowel disease gene, Science, 314, 1461, 10.1126/science.1135245 Uhlig, 2006, Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology, Immunity, 25, 309, 10.1016/j.immuni.2006.05.017 Ahern, 2010, Interleukin-23 drives intestinal inflammation through direct activity on T cells, Immunity, 33, 279, 10.1016/j.immuni.2010.08.010 Coccia, 2012, IL-1beta mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4(+) Th17 cells, J Exp Med, 209, 1595, 10.1084/jem.20111453 Caprioli, 2013, Reduction of CD68+ macrophages and decreased IL-17 expression in intestinal mucosa of patients with inflammatory bowel disease strongly correlate with endoscopic response and mucosal healing following infliximab therapy, Inflamm Bowel Dis, 19, 729, 10.1097/MIB.0b013e318280292b Rivino, 2010, CCR6 is expressed on an IL-10-producing, autoreactive memory T cell population with context-dependent regulatory function, J Exp Med, 207, 565, 10.1084/jem.20091021 Korn, 2007, Th17 cells: effector T cells with inflammatory properties, Semin Immunol, 19, 362, 10.1016/j.smim.2007.10.007 Awasthi, 2009, Cutting edge: IL-23 receptor gfp reporter mice reveal distinct populations of IL-17-producing cells, J Immunol, 182, 5904, 10.4049/jimmunol.0900732 Banham, 2006, Cell-surface IL-7 receptor expression facilitates the purification of FOXP3(+) regulatory T cells, Trends Immunol, 27, 541, 10.1016/j.it.2006.10.002 Dong, 2003, Costimulating aberrant T cell responses by B7-H1 autoantibodies in rheumatoid arthritis, J Clin Invest, 111, 363, 10.1172/JCI16015 Kuipers, 2006, Contribution of the PD-1 ligands/PD-1 signaling pathway to dendritic cell-mediated CD4+ T cell activation, Eur J Immunol, 36, 2472, 10.1002/eji.200635978 Day, 2006, PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression, Nature, 443, 350, 10.1038/nature05115 Turner, 2007, Targeting of Th1-associated chemokine receptors CXCR3 and CCR5 as therapeutic strategy for inflammatory diseases, Mini Rev Med Chem, 7, 1089, 10.2174/138955707782331768 Geginat, 2016, The light and the dark sides of Interleukin-10 in immune-mediated diseases and cancer, Cytokine Growth Factor Rev, 30, 87, 10.1016/j.cytogfr.2016.02.003 Paroni, 2016, Uncontrolled IL-17 production by intraepithelial lymphocytes in a case of non-IPEX autoimmune enteropathy, Clin Transl Gastroenterol, 7, e182, 10.1038/ctg.2016.41 Zielinski, 2012, Pathogen-induced human TH17 cells produce IFN-gamma or IL-10 and are regulated by IL-1beta, Nature, 484, 514, 10.1038/nature10957 Abraham, 2009, IL-23 and autoimmunity: new insights into the pathogenesis of inflammatory bowel disease, Annu Rev Med, 60, 97, 10.1146/annurev.med.60.051407.123757 Ramesh, 2014, Pro-inflammatory human Th17 cells selectively express P-glycoprotein and are refractory to glucocorticoids, J Exp Med, 211, 89, 10.1084/jem.20130301 Heinemann, 2014, IL-27 and IL-12 oppose pro-inflammatory IL-23 in CD4+ T cells by inducing Blimp1, Nat Commun, 5, 3770, 10.1038/ncomms4770 Gocke, 2007, T-bet regulates the fate of Th1 and Th17 lymphocytes in autoimmunity, J Immunol, 178, 1341, 10.4049/jimmunol.178.3.1341